Medtronic PLC Net Worth
Medtronic PLC Net Worth Breakdown | MDT |
Medtronic PLC Net Worth Analysis
Medtronic PLC's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Medtronic PLC's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Medtronic PLC's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Medtronic PLC's net worth analysis. One common approach is to calculate Medtronic PLC's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Medtronic PLC's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Medtronic PLC's net worth. This approach calculates the present value of Medtronic PLC's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Medtronic PLC's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Medtronic PLC's net worth. This involves comparing Medtronic PLC's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Medtronic PLC's net worth relative to its peers.
Enterprise Value |
|
To determine if Medtronic PLC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Medtronic PLC's net worth research are outlined below:
| Over 86.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Disposition of 1540 shares by Gary Corona of Medtronic PLC at 80.0 subject to Rule 16b-3 |
Medtronic PLC Quarterly Good Will |
|
Medtronic PLC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Medtronic PLC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Medtronic PLC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of May 2024 Next Financial Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View | |
| 23rd of May 2024 Next Fiscal Year End | View | |
| 31st of October 2023 Last Quarter Report | View | |
| 30th of April 2023 Last Financial Announcement | View |
Medtronic PLC Target Price Consensus
Medtronic target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Medtronic PLC's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 32 | Buy |
Most Medtronic analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Medtronic stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Medtronic PLC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMedtronic PLC Target Price Projection
Medtronic PLC's current and average target prices are 92.21 and 95.56, respectively. The current price of Medtronic PLC is the price at which Medtronic PLC is currently trading. On the other hand, Medtronic PLC's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Medtronic PLC Market Quote on 19th of March 2025
Target Price
Analyst Consensus On Medtronic PLC Target Price
Know Medtronic PLC's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Medtronic PLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medtronic PLC backward and forwards among themselves. Medtronic PLC's institutional investor refers to the entity that pools money to purchase Medtronic PLC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Franklin Resources Inc | 2024-12-31 | 16.3 M | Amvescap Plc. | 2024-12-31 | 15.4 M | Norges Bank | 2024-12-31 | 14.6 M | Royal Bank Of Canada | 2024-12-31 | 13.1 M | Northern Trust Corp | 2024-12-31 | 12.8 M | Wellington Management Company Llp | 2024-12-31 | 12.4 M | Ameriprise Financial Inc | 2024-12-31 | 12 M | Arnhold & S. Bleichroeder Advisers, Llc | 2024-12-31 | 9.8 M | American Century Companies Inc | 2024-12-31 | 9.4 M | Vanguard Group Inc | 2024-12-31 | 124.2 M | Blackrock Inc | 2024-12-31 | 114.2 M |
Follow Medtronic PLC's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 119.73 B.Market Cap |
|
Project Medtronic PLC's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.11 | 0.18 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.07 | 0.07 |
When accessing Medtronic PLC's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Medtronic PLC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Medtronic PLC's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Medtronic PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medtronic PLC. Check Medtronic PLC's Beneish M Score to see the likelihood of Medtronic PLC's management manipulating its earnings.
Evaluate Medtronic PLC's management efficiency
Medtronic PLC has Return on Asset of 0.0466 % which means that on every $100 spent on assets, it made $0.0466 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0844 %, implying that it generated $0.0844 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.18 in 2025, whereas Return On Capital Employed is likely to drop 0.05 in 2025. Total Current Liabilities is likely to gain to about 13 B in 2025. Liabilities And Stockholders Equity is likely to gain to about 108.7 B in 2025| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 38.37 | 40.29 | |
| Tangible Book Value Per Share | (6.02) | (5.72) | |
| Enterprise Value Over EBITDA | 24.28 | 12.54 | |
| Price Book Value Ratio | 3.42 | 5.46 | |
| Enterprise Value Multiple | 24.28 | 12.54 | |
| Price Fair Value | 3.42 | 5.46 | |
| Enterprise Value | 179 B | 187.9 B |
Management at Medtronic PLC focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Enterprise Value Revenue 4.1583 | Revenue | Quarterly Revenue Growth 0.025 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medtronic PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medtronic PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medtronic PLC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Medtronic PLC Corporate Filings
8K | 17th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 10th of March 2025 Other Reports | ViewVerify | |
F3 | 5th of March 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
10Q | 25th of February 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Medtronic PLC Earnings Estimation Breakdown
The calculation of Medtronic PLC's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Medtronic PLC is estimated to be 1.58 with the future projection ranging from a low of 1.36 to a high of 1.3675. Please be aware that this consensus of annual earnings estimates for Medtronic PLC is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
1.36 Lowest | Expected EPS | 1.37 Highest |
Medtronic PLC Earnings Projection Consensus
Suppose the current estimates of Medtronic PLC's value are higher than the current market price of the Medtronic PLC stock. In this case, investors may conclude that Medtronic PLC is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Medtronic PLC's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of April 2025 | Current EPS (TTM) | |
| 32 | 97.48% | 1.39 | 1.58 | 3.28 |
Medtronic PLC Earnings History
Earnings estimate consensus by Medtronic PLC analysts from Wall Street is used by the market to judge Medtronic PLC's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Medtronic PLC's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Medtronic PLC Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medtronic PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medtronic PLC Earnings per Share Projection vs Actual
Actual Earning per Share of Medtronic PLC refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Medtronic PLC predict the company's earnings will be in the future. The higher the earnings per share of Medtronic PLC, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Medtronic PLC Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Medtronic PLC, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Medtronic PLC should always be considered in relation to other companies to make a more educated investment decision.Medtronic Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Medtronic PLC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-18 | 2025-01-31 | 1.3595 | 1.39 | 0.0305 | 2 | ||
2024-11-19 | 2024-10-31 | 1.25 | 1.26 | 0.01 | 0 | ||
2024-08-20 | 2024-07-31 | 1.2 | 1.23 | 0.03 | 2 | ||
2024-05-23 | 2024-04-30 | 1.45 | 1.46 | 0.01 | 0 | ||
2024-02-20 | 2024-01-31 | 1.26 | 1.3 | 0.04 | 3 | ||
2023-11-21 | 2023-10-31 | 1.18 | 1.25 | 0.07 | 5 | ||
2023-08-22 | 2023-07-31 | 1.11 | 1.2 | 0.09 | 8 | ||
2023-05-25 | 2023-04-30 | 1.56 | 1.57 | 0.01 | 0 | ||
2023-02-21 | 2023-01-31 | 1.27 | 1.3 | 0.03 | 2 | ||
2022-11-22 | 2022-10-31 | 1.28 | 1.3 | 0.02 | 1 | ||
2022-08-23 | 2022-07-31 | 1.12 | 1.13 | 0.01 | 0 | ||
2022-05-26 | 2022-04-30 | 1.56 | 1.52 | -0.04 | 2 | ||
2022-02-22 | 2022-01-31 | 1.36 | 1.37 | 0.01 | 0 | ||
2021-11-23 | 2021-10-31 | 1.29 | 1.32 | 0.03 | 2 | ||
2021-08-24 | 2021-07-31 | 1.32 | 1.41 | 0.09 | 6 | ||
2021-05-27 | 2021-04-30 | 1.42 | 1.5 | 0.08 | 5 | ||
2021-02-23 | 2021-01-31 | 1.15 | 1.29 | 0.14 | 12 | ||
2020-11-24 | 2020-10-31 | 0.8 | 1.02 | 0.22 | 27 | ||
2020-08-25 | 2020-07-31 | 0.18 | 0.62 | 0.44 | 244 | ||
2020-05-21 | 2020-04-30 | 0.68 | 0.58 | -0.1 | 14 | ||
2020-02-18 | 2020-01-31 | 1.38 | 1.44 | 0.06 | 4 | ||
2019-11-19 | 2019-10-31 | 1.28 | 1.31 | 0.03 | 2 | ||
2019-08-20 | 2019-07-31 | 1.18 | 1.26 | 0.08 | 6 | ||
2019-05-23 | 2019-04-30 | 1.46 | 1.54 | 0.08 | 5 | ||
2019-02-19 | 2019-01-31 | 1.24 | 1.29 | 0.05 | 4 | ||
2018-11-20 | 2018-10-31 | 1.15 | 1.22 | 0.07 | 6 | ||
2018-08-21 | 2018-07-31 | 1.11 | 1.17 | 0.06 | 5 | ||
2018-05-24 | 2018-04-30 | 1.39 | 1.42 | 0.03 | 2 | ||
2018-02-20 | 2018-01-31 | 1.17 | 1.17 | 0.0 | 0 | ||
2017-11-21 | 2017-10-31 | 0.98 | 1.07 | 0.09 | 9 | ||
2017-08-22 | 2017-07-31 | 1.08 | 1.12 | 0.04 | 3 | ||
2017-05-25 | 2017-04-30 | 1.31 | 1.33 | 0.02 | 1 | ||
2017-02-21 | 2017-01-31 | 1.11 | 1.12 | 0.01 | 0 | ||
2016-11-22 | 2016-10-31 | 1.11 | 1.12 | 0.01 | 0 | ||
2016-08-25 | 2016-07-31 | 1.01 | 1.03 | 0.02 | 1 | ||
2016-05-31 | 2016-04-30 | 1.26 | 1.27 | 0.01 | 0 | ||
2016-03-01 | 2016-01-31 | 1.06 | 1.06 | 0.0 | 0 | ||
2015-12-03 | 2015-10-31 | 1 | 1.03 | 0.03 | 3 | ||
2015-09-03 | 2015-07-31 | 1.01 | 1.02 | 0.01 | 0 | ||
2015-06-02 | 2015-04-30 | 1.11 | 1.16 | 0.05 | 4 | ||
2015-02-17 | 2015-01-31 | 0.97 | 1.01 | 0.04 | 4 | ||
2014-11-18 | 2014-10-31 | 0.96 | 0.96 | 0.0 | 0 | ||
2014-08-19 | 2014-07-31 | 0.92 | 0.93 | 0.01 | 1 | ||
2014-05-20 | 2014-04-30 | 1.12 | 1.12 | 0.0 | 0 | ||
2014-02-18 | 2014-01-31 | 0.91 | 0.91 | 0.0 | 0 | ||
2013-11-19 | 2013-10-31 | 0.9 | 0.91 | 0.01 | 1 | ||
2013-08-20 | 2013-07-31 | 0.88 | 0.88 | 0.0 | 0 | ||
2013-05-21 | 2013-04-30 | 1.03 | 1.1 | 0.07 | 6 | ||
2013-02-19 | 2013-01-31 | 0.91 | 0.93 | 0.02 | 2 | ||
2012-11-20 | 2012-10-31 | 0.88 | 0.88 | 0.0 | 0 | ||
2012-08-21 | 2012-07-31 | 0.85 | 0.85 | 0.0 | 0 | ||
2012-05-22 | 2012-04-30 | 0.98 | 0.99 | 0.01 | 1 | ||
2012-02-21 | 2012-01-31 | 0.84 | 0.84 | 0.0 | 0 | ||
2011-11-22 | 2011-10-31 | 0.82 | 0.84 | 0.02 | 2 | ||
2011-08-23 | 2011-07-31 | 0.79 | 0.79 | 0.0 | 0 | ||
2011-05-24 | 2011-04-30 | 0.92 | 0.9 | -0.02 | 2 | ||
2011-02-22 | 2011-01-31 | 0.84 | 0.86 | 0.02 | 2 | ||
2010-11-23 | 2010-10-31 | 0.81 | 0.82 | 0.01 | 1 | ||
2010-08-24 | 2010-07-31 | 0.8 | 0.8 | 0.0 | 0 | ||
2010-05-25 | 2010-04-30 | 0.88 | 0.9 | 0.02 | 2 | ||
2010-02-23 | 2010-01-31 | 0.76 | 0.77 | 0.01 | 1 | ||
2009-11-24 | 2009-10-31 | 0.74 | 0.77 | 0.03 | 4 | ||
2009-08-25 | 2009-07-31 | 0.78 | 0.79 | 0.01 | 1 | ||
2009-05-19 | 2009-04-30 | 0.82 | 0.82 | 0.0 | 0 | ||
2009-02-17 | 2009-01-31 | 0.7 | 0.71 | 0.01 | 1 | ||
2008-11-18 | 2008-10-31 | 0.71 | 0.67 | -0.04 | 5 | ||
2008-08-19 | 2008-07-31 | 0.69 | 0.72 | 0.03 | 4 | ||
2008-05-20 | 2008-04-30 | 0.73 | 0.78 | 0.05 | 6 | ||
2008-02-19 | 2008-01-31 | 0.61 | 0.63 | 0.02 | 3 | ||
2007-11-19 | 2007-10-31 | 0.56 | 0.58 | 0.02 | 3 | ||
2007-08-21 | 2007-07-31 | 0.62 | 0.62 | 0.0 | 0 | ||
2007-05-22 | 2007-04-30 | 0.62 | 0.66 | 0.04 | 6 | ||
2007-02-20 | 2007-01-31 | 0.58 | 0.61 | 0.03 | 5 | ||
2006-11-20 | 2006-10-31 | 0.56 | 0.59 | 0.03 | 5 | ||
2006-08-22 | 2006-07-31 | 0.54 | 0.55 | 0.01 | 1 | ||
2006-05-23 | 2006-04-30 | 0.62 | 0.62 | 0.0 | 0 | ||
2006-02-21 | 2006-01-31 | 0.55 | 0.55 | 0.0 | 0 | ||
2005-11-16 | 2005-10-31 | 0.54 | 0.54 | 0.0 | 0 | ||
2005-08-17 | 2005-07-31 | 0.49 | 0.5 | 0.01 | 2 | ||
2005-05-24 | 2005-04-30 | 0.53 | 0.53 | 0.0 | 0 | ||
2005-02-16 | 2005-01-31 | 0.46 | 0.46 | 0.0 | 0 | ||
2004-11-17 | 2004-10-31 | 0.45 | 0.44 | -0.01 | 2 | ||
2004-08-18 | 2004-07-31 | 0.43 | 0.43 | 0.0 | 0 | ||
2004-05-24 | 2004-04-30 | 0.46 | 0.48 | 0.02 | 4 | ||
2004-02-11 | 2004-01-31 | 0.4 | 0.4 | 0.0 | 0 | ||
2003-11-12 | 2003-10-31 | 0.39 | 0.39 | 0.0 | 0 | ||
2003-08-12 | 2003-07-31 | 0.37 | 0.37 | 0.0 | 0 | ||
2003-05-19 | 2003-04-30 | 0.4 | 0.4 | 0.0 | 0 | ||
2003-02-12 | 2003-01-31 | 0.35 | 0.35 | 0.0 | 0 | ||
2002-11-18 | 2002-10-31 | 0.34 | 0.34 | 0.0 | 0 | ||
2002-08-20 | 2002-07-31 | 0.32 | 0.32 | 0.0 | 0 | ||
2002-05-22 | 2002-04-30 | 0.34 | 0.34 | 0.0 | 0 | ||
2002-02-19 | 2002-01-31 | 0.3 | 0.3 | 0.0 | 0 | ||
2001-11-27 | 2001-10-31 | 0.29 | 0.29 | 0.0 | 0 | ||
2001-08-20 | 2001-07-31 | 0.27 | 0.28 | 0.01 | 3 | ||
2001-05-22 | 2001-04-30 | 0.3 | 0.3 | 0.0 | 0 | ||
2001-02-21 | 2001-01-31 | 0.26 | 0.26 | 0.0 | 0 | ||
2000-11-20 | 2000-10-31 | 0.26 | 0.26 | 0.0 | 0 | ||
2000-08-21 | 2000-07-31 | 0.25 | 0.25 | 0.0 | 0 | ||
2000-05-24 | 2000-04-30 | 0.26 | 0.26 | 0.0 | 0 | ||
2000-02-23 | 2000-01-31 | 0.23 | 0.23 | 0.0 | 0 | ||
1999-11-22 | 1999-10-31 | 0.22 | 0.22 | 0.0 | 0 | ||
1999-08-23 | 1999-07-31 | 0.21 | 0.21 | 0.0 | 0 | ||
1999-05-27 | 1999-04-30 | 0.21 | 0.21 | 0.0 | 0 | ||
1999-02-24 | 1999-01-31 | 0.18 | 0.18 | 0.0 | 0 | ||
1998-11-17 | 1998-10-31 | 0.17 | 0.17 | 0.0 | 0 | ||
1998-08-18 | 1998-07-31 | 0.16 | 0.16 | 0.0 | 0 | ||
1998-05-26 | 1998-04-30 | 0.17 | 0.17 | 0.0 | 0 | ||
1998-02-18 | 1998-01-31 | 0.16 | 0.15 | -0.01 | 6 | ||
1997-11-18 | 1997-10-31 | 0.16 | 0.16 | 0.0 | 0 | ||
1997-08-19 | 1997-07-31 | 0.15 | 0.16 | 0.01 | 6 | ||
1997-05-22 | 1997-04-30 | 0.15 | 0.16 | 0.01 | 6 | ||
1997-02-18 | 1997-01-31 | 0.14 | 0.14 | 0.0 | 0 | ||
1996-11-19 | 1996-10-31 | 0.13 | 0.14 | 0.01 | 7 | ||
1996-08-19 | 1996-07-31 | 0.13 | 0.13 | 0.0 | 0 | ||
1996-05-23 | 1996-04-30 | 0.13 | 0.14 | 0.01 | 7 |
Medtronic PLC Corporate Directors
| Scott Donnelly | Lead Independent Director | Profile | |
| Richard Anderson | Lead Independent Director | Profile | |
| Elizabeth Nabel | Independent Director | Profile | |
| James Lenehan | Independent Director | Profile |
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.